Skip to main content
Reset

Advanced Filters

Advanced Search Help

Standard search functionality is for the search to return results that contain all words entered into the search bar.

Exact Phrase Match Search - Use quotations around a phrase to only return results that are an exact match to the search term entered. Example: "example text"

Exclusion Search - Use the minus sign to only return results that do not include your search term. -example

Either/Or Search - Use the word OR in between words to return results that include either or both words. Example: example OR test

Use advanced filters to allow you to further drill down and limit your search results! Such as selecting two dates to only display matching search results which occur on either of those days.

Search options can be combined in limited ways to increase the accuracy of your search results. Example: A search for "intellectual property" and electrochemistry.

Advanced Filters
  • Displaying 40 - 50 of 204
  • First
  • «
  • 3
  • 4
  • 5
  • 6
  • 7
  • »
  • Last
Perceptions of CARTITUDE-4 for Patients With Relapsed/Refractory Multiple Myeloma
Brooke Dulka, PhD, Author
Tags: Outcomes and Health Services Research
View Poster


Abstract: JNCCN23-0561 https://jnccn.org/view/journal...



Author(s):
  • Brooke Dulka, PhD

Tags: Outcomes and Health Services Research
Characteristics of Individuals and Genomic Testing in Early-Onset GI Cancers in the Southeastern USCharacteristics of Individuals and Genomic Testing in Early-Onset GI Cancers in the Southeastern US
Characteristics of Individuals and Genomic Testing in Early-Onset GI Cancers in the Southeastern US
Amy F. Ballou, DNP, MSN, ACNP-BC, Author
Tags: EpidemiologyRisksPrevention
View Poster


Abstract: JNCCN23-0550 https://jnccn.org/view/journal...



Author(s):
  • Amy F. Ballou, DNP, MSN, ACNP-BC

Tags: EpidemiologyRisksPrevention
Reporting the False Negative Rate of Sentinel Lymph Node Biopsy for Melanoma: A Useful Quality Control MetricReporting the False Negative Rate of Sentinel Lymph Node Biopsy for Melanoma: A Useful Quality Control Metric
Reporting the False Negative Rate of Sentinel Lymph Node Biopsy for Melanoma: A Useful Quality Control Metric
Carly McCain, BS, BSN, Author
Tags: Best Practices in Implementation and Use of Clinical Practice Gu
View Poster


Abstract: JNCCN23-0548 https://jnccn.org/view/journal...



Author(s):
  • Carly McCain, BS, BSN

Tags: Best Practices in Implementation and Use of Clinical Practice Gu
Impact of Somatic Mutations on Outcomes of Salvage Radiation and Hormonal Therapy for Prostate Cancer Recurrence After ProstatectomyImpact of Somatic Mutations on Outcomes of Salvage Radiation and Hormonal Therapy for Prostate Cancer Recurrence After Prostatectomy
Impact of Somatic Mutations on Outcomes of Salvage Radiation and Hormonal Therapy for Prostate Cancer Recurrence After Prostatectomy
Keisuke T. Otani, MD, PhD, Author
Tags: Member Institution CorrelativeGenomic
View Poster


Abstract: JNCCN23-0747 https://jnccn.org/view/journal...



Author(s):
  • Keisuke T. Otani, MD, PhD

Tags: Member Institution CorrelativeGenomic
Autonomic Symptoms May Suggest Paraneoplastic Neurological Syndromes in Small Cell Lung CancerAutonomic Symptoms May Suggest Paraneoplastic Neurological Syndromes in Small Cell Lung Cancer
Autonomic Symptoms May Suggest Paraneoplastic Neurological Syndromes in Small Cell Lung Cancer
Guy Shechter, PhD, MBA, Author
Tags: Outcomes and Health Services Research
View Poster


Abstract: JNCCN23-0710 https://jnccn.org/view/journal...



Author(s):
  • Guy Shechter, PhD, MBA

Tags: Outcomes and Health Services Research
Results From the Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion-Dependent Non-del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating AgentsResults From the Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion-Dependent Non-del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents
Results From the Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion-Dependent Non-del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents
Yazan Madanat, MD, Author
Tags: Member Institution Clinical Oncology Top Abstract
View Poster


Abstract: JNCCN23-0640 https://jnccn.org/view/journal...



Author(s):
  • Yazan Madanat, MD

Tags: Member Institution Clinical Oncology Top Abstract
The Clinical Effect of a Community-Based Genetic Testing ProgramThe Clinical Effect of a Community-Based Genetic Testing Program
The Clinical Effect of a Community-Based Genetic Testing Program
Danielle Brabender, MD, Author
Tags: EpidemiologyRisksPrevention Top Abstract
View Poster


Abstract: JNCCN23-0638 https://jnccn.org/view/journal...



Author(s):
  • Danielle Brabender, MD

Tags: EpidemiologyRisksPrevention Top Abstract
Comparing "Apples to Apples" in Uterine Cancer: Racial Disparity and Propensity Score Matching
Alexandrina Balanean, MPH, Author
Tags: Outcomes and Health Services Research Top Abstract
View Poster


Abstract: JNCCN23-0718 https://jnccn.org/view/journal...



Author(s):
  • Alexandrina Balanean, MPH

Tags: Outcomes and Health Services Research Top Abstract
Improved Access through an Integrated Supportive Care Model Reduced Urgent Care Referral and Admission Rates for Patients with Gastrointestinal MalignancyImproved Access through an Integrated Supportive Care Model Reduced Urgent Care Referral and Admission Rates for Patients with Gastrointestinal Malignancy
Improved Access through an Integrated Supportive Care Model Reduced Urgent Care Referral and Admission Rates for Patients with Gastrointestinal Malignancy
Adrianna Oraiqat, BS, Author
Tags: Member Institution Outcomes and Health Services Research Top Abstract
View Poster


Abstract: JNCCN23-0703 https://jnccn.org/view/journal...



Author(s):
  • Adrianna Oraiqat, BS

Tags: Member Institution Outcomes and Health Services Research Top Abstract
Trial in Progress: A Multi-Center Phase I Trial of Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Refractory Gastric Cancer PatientsTrial in Progress: A Multi-Center Phase I Trial of Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Refractory Gastric Cancer Patients
Trial in Progress: A Multi-Center Phase I Trial of Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Refractory Gastric Cancer Patients
Rima Nakrani, MD, MSc, Author
Tags: Member Institution ORP Trials in Progress
View Poster


Abstract: JNCCN23-0723 https://jnccn.org/view/journal...



Author(s):
  • Rima Nakrani, MD, MSc

Tags: Member Institution ORP Trials in Progress
  • Displaying 40 - 50 of 204
  • First
  • «
  • 3
  • 4
  • 5
  • 6
  • 7
  • »
  • Last